Revolutionizing Heart Health: The SCAPIS Initiative Aims to Prevent Heart Attacks
Every year, approximately 8,000 people under the age of 70 experience their first heart attack in Sweden, leading to over 1,000 deaths. Göran Bergström, the chief physician at Sahlgrenska University Hospital in Gothenburg, is spearheading a groundbreaking initiative aimed at changing these statistics by 2030.
Bergström is not only a prominent physician but also the scientific lead for the SCAPIS study, which stands for the Swedish CardioPulmonary bioImage Study. This ambitious project represents the largest investigation of its kind globally that targets heart and lung diseases. Collaborating with six universities and university hospitals, SCAPIS aims to examine 30,000 individuals, ultimately seeking to predict and, importantly, prevent heart and lung diseases before they manifest.
One of the major goals of SCAPIS is to identify asymptomatic individuals who possess an unseen risk of heart attacks. "I really want to find tools to identify those individuals," Bergström states. "That’s where SCAPIS is super interesting."
The vast pool of 30,000 participants has undergone various examinations, focusing mainly on the heart's blood vessels. Alarmingly, researchers detected changes that could indicate a risk of heart attack in more than 40% of those examined. While most participants showed only minor changes, approximately one in 20 exhibited significant alterations without prior awareness. This underscores the silent nature of many heart risks and highlights the necessity for effective screening methods.
Bergström emphasizes the potential for the research to lead to breakthroughs in identifying high-risk individuals through more accessible methods, possibly even a simple blood test. "If we find these individuals, we can provide preventive assistance so that they do not have a heart attack," he explains. He also mentions that many interventions depend on lifestyle alterations, but advances in medication are promising.
A revolutionary aspect of SCAPIS could be the development of cost-effective screening techniques. "What could be revolutionary is if we find simple ways to identify high-risk individuals. Perhaps we can measure something in the blood that becomes a test that isn’t too expensive," Bergström notes. His aim is to reduce the number of people in the risk zone by 20 to 30 percent through these new preventative strategies.
However, SCAPIS is an extensive and costly study. The Heart-Lung Foundation primarily finances this ambitious research, and every donation, no matter how small, contributes to advancing the study's objectives. "We can measure many things in the blood of these individuals, but we still cannot afford to measure everything we want to measure. I think soon ideas for a solution will come, and it’s financing that enables us to take that step,” Bergström concludes.
In an era where preventative health care is more critical than ever, SCAPIS offers hope not just for individuals at risk, but for the broader public health landscape. The initiative represents a significant step towards understanding and ultimately preventing heart diseases before they strike.
Related Sources: